What Do You Get When a Stock Picker Decides to Fix Your Knees? Apparently… Hope

So, Who’s Trying to Actually Fix This?

Cue; Joey Bose, CEO of Cytonics; a guy who used to help investors pick winning companies… and then decided to build one himself.

Since 2018, he’s been laser-focused on flipping the script. Not selling hope; building it.

“A true therapy must address the root molecular cause of osteoarthritis,” Joey says. “We’re not here to slap a patch on pain, we’re here to stop it at the source.”

That’s not a motto, that’s a mission.


So What Exactly Is Cytonics Doing?

Let’s break it down like a Sunday morning pancake recipe.

Inside your joints, there are tiny enzymes. Let’s call them cartilage-eating gremlins; that slowly, steadily, chew away at the stuff that makes your knees, hips, and shoulders function.

The problem? Your body doesn’t make enough of it in the joints.

So Cytonics engineered a next-level version of A2M, called CYT-108. It’s:

• Over 200% more effective than the natural stuff
• Designed to be injected directly into joints
• Built to eliminate those enzymes that cause long-term cartilage damage

This is not about mere pain management…not to mask it, not to manage it, and not to wait until you’re metal from the knee down. Treat it at the root molecular cause of the disease; that’s the play.


Why Should You Care?

Well, let’s flip the question: Do you enjoy recreational sports? Want to throw a baseball with your kid at 55? Want to avoid telling your spouse, “Go without me” because your hip is acting up again?

Ever thought, “I hope I don’t end up in one of those scooters at Costco”?

Then this affects you.

And even if you’re young and spry today, your joints are still collecting mileage. Spoiler: knees don’t have a warranty.


And Here’s the Twist: You Can Help Build This

Joey and the Cytonics team didn’t go knocking on Big Pharma’s door.

Instead, they opened the door to you.

• 6,000+ everyday investors have already backed the company
• $25M+ raised
• First-gen therapy already FDA-cleared and used on 10,000+ people
• Next-gen therapy is ready for Phase 2 trials, the “real deal” stage of clinical development
• And they hold 25+ patents protecting their innovation

This isn’t a stock tip, this is a chance to own part of something meaningful. Something that could genuinely improve lives and maybe your own.

Joey didn’t set out to be the face of joint health.

He just saw a system that was failing half-a-billion people and said, “Nope, not good enough.”

And now? You have a shot at being part of the story.

Because this isn’t just a fight against pain, it’s a fight for freedom. For movement, for being able to live the life you want at any age.

So whether you’re in your 30s hoping to stay active… Or in your 60s trying to stay off the operating table… Or just someone who believes science should actually solve problems… This is your moment to move before pain makes that decision for you.

Let’s go.